Ranbaxy Laboratories Ltd (RANB.NS) Quote| Reuters.com
United States

Ranbaxy Laboratories Ltd (RANB.NS)

RANB.NS on National Stock Exchange of India

1 Apr 2015
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for RANB.NS


Ranbaxy Laboratories Limited (Ranbaxy) is a research-based international pharmaceutical company serving customers in over 150 countries. The Company develops, manufactures and markets generic, branded generic, value-added and over-the-counter (OTC) products, anti-retrovirals (ARVs), active pharmaceutical ingredients (APIs) and... (more)


Beta: 0.34
Market Cap(Mil.): Rs365,985.50
Shares Outstanding(Mil.): 425.66
Dividend: --
Yield (%): --


  RANB.NS Industry Sector
P/E (TTM): -- 32.69 34.11
EPS (TTM): -19.13 -- --
ROI: -- 15.00 14.23
ROE: -- 16.08 15.46

BRIEF-Daiichi Sankyo announces outcome of arbitration proceeding with Ranbaxy

* Says Daiichi Sankyo received a final award in the arbitration that it filed with the International Court of Arbitration of the International Chamber of Commerce in November 2012 against the former shareholders Ranbaxy Laboratories Ltd. on May 3

May 06 2016

Japanese drugmaker Daiichi wins damages from former Ranbaxy owners

MUMBAI The former owners of Indian drugmaker Ranbaxy Laboratories have been ordered by an arbitration court to pay damages worth 25.63 billion rupees ($385 million) to Japan's Daiichi Sankyo Co Ltd, they said on Thursday.

May 05 2016

Pharma crusader takes India's drug regulators to court

* Bringing public interest suit against health ministry, regulator

Mar 07 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
Provider : MarketLine
Provider : Thomson Reuters Stock Report
Provider : Wright Reports
Provider : GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.